Core Insights - LifeVantage Corporation announced new in vitro study results for its proprietary P84 formula, demonstrating significant biological activity in cellular pathways related to gut regulation, repair, and restoration [1][2] Group 1: Study Findings - The study measured targeted gene expression and protein concentration across four gut cell types, examining 14 gut peptides and proteins that regulate gut health [1] - All 14 peptides were positively influenced, with notable increases such as GRP (gastrin-releasing peptide) showing an increase of 1,087%, TFF3 (trefoil factor 3) increasing by 116%, and VIP (vasoactive intestinal peptide) increasing by 100% [6] - The results exceeded typical biomarker changes of 20-30%, indicating a strong impact of P84 on gut health [2] Group 2: Product Development and Strategy - The next phase of research will involve mRNA sequencing analysis of the P84 blend in combination with other LifeVantage products, including Protandim Nrf2 Synergizer and MindBody GLP-1 System™ [3] - LifeVantage integrated P84 into its product portfolio following the acquisition of LoveBiome, a company focused on gut and microbiome health, in October 2025 [4] - P84 is marketed as part of the Healthy Edge Stack, aimed at enhancing consumer health through cellular activation [4] Group 3: Company Overview - LifeVantage Corporation is a pioneer in nutrigenomics, focusing on how nutrition and natural compounds can influence gene expression and health [5] - The company offers a range of scientifically validated products, including the Protandim® family, TrueScience® Liquid Collagen, and the comprehensive gut activator P84 [5]

Core Insights - LifeVantage Corporation successfully concluded Momentum Academy 2025, an event aimed at empowering Consultants and enhancing business engagement [1][5] - The event marked the first integration of LoveBiome Consultants with LifeVantage, fostering collaboration and alignment between the two companies [2][5] Event Overview - Momentum Academy 2025 took place from October 23-25 at the Hilton Anatole in Dallas, TX, under the theme "Love Life & Drive" [1][2] - The event featured workshops, seminars, and keynotes focused on business acceleration, leadership potential, enrollment, retention, and advancement strategies [3] Product Launch - Attendees were introduced to Healthy Edge, combining Protandim® Nrf2 Synergizer with LoveBiome P84, aimed at supporting cellular health [4] - This event marked the first opportunity for Consultants and consumers to purchase LoveBiome P84 directly through LifeVantage, alongside other exclusive products [4] Company Vision - The President and CEO of LifeVantage emphasized the importance of unity and empowerment among Consultants, highlighting the innovative spirit of the company [5] - LifeVantage positions itself as a pioneer in nutrigenomics, focusing on products that activate health at the cellular level [7]

Core Insights - LifeVantage Corporation, a health and wellness company, will have its CEO Steve Fife participate in the LD Micro Main Event XIX from October 19-21, 2025 [1] - Fife's presentation is scheduled for October 20, 2025, at approximately 5:30 p.m. Eastern Time, with a live webcast available for investors [2] Company Overview - LifeVantage Corporation specializes in nutrigenomics, focusing on how nutrition and natural compounds can activate health at the cellular level [3] - The company offers a range of products, including the Protandim® family, TrueScience® Liquid Collagen, MindBody GLP-1 System™, and various health-supporting nutrients [3] - Founded in 2003 and headquartered in Lehi, Utah, LifeVantage operates through independent consultants who sell products and promote business opportunities [3]

Core Insights - LifeVantage Corporation has successfully completed the acquisition of LoveBiome, enhancing its position in the direct sales and gut health market [1][2] - The acquisition allows LifeVantage to expand its product portfolio into the growing microbiome health sector and strengthen its market presence in the US, Taiwan, and Europe [2] Company Overview - LifeVantage Corporation is a pioneer in nutrigenomics, focusing on how nutrition and natural compounds can activate health at the cellular level [3] - The company offers a range of scientifically validated products, including the Protandim® family, TrueScience® Liquid Collagen, and various health-supporting nutrients [3] - LifeVantage operates through independent consultants who sell products and provide business opportunities to aspiring entrepreneurs [3]

Group 1 - LifeVantage Corporation will participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025, with CEO Steve Fife and CFO Carl Aure presenting [1][2] - The presentation is scheduled for approximately 11:00 a.m. Eastern Time and will be available via a live webcast on the company's Investor Relations website [2] - LifeVantage specializes in nutrigenomics, offering products that activate health processes at the cellular level, including the Protandim® family, TrueScience® Liquid Collagen, and various health-supporting nutrients [3] Group 2 - LifeVantage was founded in 2003 and is headquartered in Lehi, Utah, focusing on health and wellness products that work with individual biology [3] - The company also provides a business opportunity for independent consultants to sell its products and promote entrepreneurship [3]

Core Insights - LifeVantage Corporation reported a strong financial performance for the fourth quarter and full fiscal year 2025, with a revenue growth of approximately 13% to $55.1 million in Q4 and 14.2% to $228.5 million for the full year [6][9][14] - The international business showed growth for the first time in nearly three years, particularly in the Asia/Pacific and Europe regions, which increased by approximately 8% [6][9] - The company has a strong balance sheet with $20.2 million in cash and no debt, positioning it well for future growth [22] Fourth Quarter Fiscal 2025 Summary - Revenue for Q4 was $55.1 million, a 12.6% increase year-over-year, with a 14.1% increase in the Americas and a 7.6% increase in Asia/Pacific & Europe [7][9] - Gross profit was $44.0 million, representing 79.9% of revenue, compared to 79.5% in Q4 fiscal 2024 [8] - Net income for Q4 was $2.0 million, or $0.15 per diluted share, up from $1.3 million, or $0.10 per diluted share in the prior year [12][9] Fiscal Year 2025 Summary - Total revenue for fiscal 2025 was $228.5 million, a 14.2% increase from $200.2 million in fiscal 2024 [14] - Gross profit for the year was $183.7 million, or 80.4% of revenue, compared to 79.3% in fiscal 2024 [15] - Net income for the year was $9.8 million, or $0.75 per diluted share, compared to $2.9 million, or $0.23 per diluted share in fiscal 2024 [19] Share Repurchase and Dividend - The company repurchased 0.3 million shares for $3.1 million during fiscal 2025, with approximately $17.3 million remaining under the current repurchase program [21] - A cash dividend of $0.045 per common share was declared, to be paid on September 16, 2025 [23] Fiscal Year 2026 Guidance - LifeVantage expects revenue in the range of $225 million to $240 million for fiscal 2026, with adjusted EBITDA of $23 million to $26 million [24]

Core Insights - LifeVantage Corporation has announced a definitive agreement to acquire LoveBiome, a direct sales company focused on microbiome health solutions, enhancing its position in the gut health market [1][3] - The acquisition aligns with LifeVantage's mission to activate optimal health processes and expand its product offerings in the growing gut health sector [1][5] - The global gut health supplement market is projected to grow from $14.4 billion in 2025 to $32.4 billion by 2035, with a robust CAGR of 8.4% [5] Company Strategy - The acquisition of LoveBiome is seen as a strategic move to enhance LifeVantage's Activation differentiation and broaden its community reach [1][5] - LifeVantage aims to leverage LoveBiome's expertise in microbiome science to complement its existing product portfolio, including the Protandim® family and MindBody GLP-1 System™ [1][5] - The integration of LoveBiome's innovative P84 product is expected to strengthen LifeVantage's offerings in gut health, which is increasingly recognized for its impact on overall wellness [1][5] Transaction Details - LifeVantage will acquire LoveBiome's critical operating assets and retain key personnel, including founder Kelly Olsen, to ensure operational continuity [3] - The acquisition is expected to close by mid-October, pending customary closing conditions and regulatory approvals [3] - The transaction is anticipated to enhance revenue growth and be accretive to Adjusted EPS and Adjusted EBITDA in the first year, with additional synergy opportunities [5]

Core Insights - LifeVantage Corporation will release its financial results for the fourth quarter and full fiscal year ended June 30, 2025, on September 4, 2025, after market close [1] - A conference call for investors will take place on the same day at 2:30 p.m. Mountain Time [1] Financial Results Announcement - The financial results will cover the fourth quarter and the full fiscal year ending June 30, 2025 [1] - The announcement will be made after the stock market closes on September 4, 2025 [1] Conference Call Details - Investors can participate in the live call by dialing (877) 704-4453 from the U.S. or (201) 389-0920 for international callers [2] - A telephone replay will be available approximately two hours after the call and will last until September 18, 2025 [2] Webcast Information - A live webcast of the conference call will be available on the Investor Relations section of the company's website [3] - The webcast will be archived for approximately 30 days [3] Company Overview - LifeVantage Corporation is a pioneer in nutrigenomics, focusing on how nutrition and natural compounds can enhance health at the cellular level [4] - The company offers a range of products, including the Protandim® family, TrueScience® Liquid Collagen, and various health-supporting nutrients [4] - LifeVantage was founded in 2003 and is headquartered in Lehi, Utah [4]

Core Insights - LifeVantage Corporation is set to launch its products in Iceland in September 2025, marking a significant step in its international expansion strategy [1][4] - The launch will feature a selection of top-performing products and three curated wellness stacks tailored to various health goals, with plans for additional products in the future [2][4] - The introduction of the LifeVantage business opportunity in Iceland will be supported by the Evolve Compensation Plan, allowing consultants to enroll for the launch [3][4] Company Overview - LifeVantage Corporation specializes in nutrigenomics, focusing on how nutrition and natural compounds can enhance health at the cellular level [6] - The company's product line includes scientifically validated activators such as Protandim®, TrueScience® Liquid Collagen, and the MindBody GLP-1 System™, among others [6][7] - LifeVantage operates through independent consultants who sell products and promote business opportunities to aspiring entrepreneurs [6] Leadership Perspective - Steve Fife, President and CEO, expressed excitement about the Iceland launch, emphasizing its role in empowering individuals with health tools and supporting their entrepreneurial journeys [4]

Core Insights - LifeVantage Corporation announced new results from its second human clinical study on the MindBody GLP-1 System™, showing significant improvements in GLP-1 levels and related health outcomes [1][2] Clinical Study Results - The average increase in GLP-1 production improved to over 200%, up from a previously reported 140% [2] - Participants experienced an average weight loss of 11 pounds within 12 weeks, with some losing up to 25 pounds [6] - There was a reported decrease in total body fat percentage of up to 9% and a decrease in visceral fat of up to 24% [6] - Participants reported a 100% weight loss from fat, not muscle, and a 6% increase in skeletal muscle [6] Behavioral Changes - 95% of participants reported decreased sugar cravings, while 89% reported decreased fast-food cravings [6] - 85% of participants indicated they now eat for health instead of emotions, and 81% reported an increased ability to resist snacking [6] - 89% of participants ate less at meals, and 86% reported feeling less hungry [6] Company Background - LifeVantage Corporation is a pioneer in nutrigenomics, focusing on how nutrition and natural compounds can enhance health [5] - The company offers a range of products, including the MindBody GLP-1 System™, aimed at promoting optimal health at the cellular level [5]